Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Are thyrotropin-releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid-induced respiratory depression?
Pharmacol Res Perspect. 2022 Jun;10(3):e00974. doi: 10.1002/prp2.974.
Pharmacol Res Perspect. 2022.
PMID: 35621218
Free PMC article.
Review.
A Comparison of Breathing Stimulants for Reversal of Synthetic Opioid-Induced Respiratory Depression in Conscious Rats.
Dandrea KE, Cotten JF.
Dandrea KE, et al.
J Pharmacol Exp Ther. 2021 Aug;378(2):146-156. doi: 10.1124/jpet.121.000675. Epub 2021 May 21.
J Pharmacol Exp Ther. 2021.
PMID: 34021024
Free PMC article.
Item in Clipboard
Respiratory effects of thyrotropin-releasing hormone and its analogue taltirelin on opioid-induced respiratory depression.
Algera MH, Cotten JF, van Velzen M, Niesters M, Boon M, Shoham DS, Dandrea KE, van der Schrier R, Dahan A.
Algera MH, et al.
Br J Anaesth. 2022 Jul;129(1):e4-e6. doi: 10.1016/j.bja.2022.03.022. Epub 2022 Apr 19.
Br J Anaesth. 2022.
PMID: 35459532
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite